Ocrevuscopay বিকল্প & প্রতিযোগীরা
Ocrevus.
বিকল্প এবং প্রতিযোগীদের ocrevuscopay.com বিষয়বস্তু, ট্রাফিক এবং গঠন পরিপ্রেক্ষিতে
Learn about OCREVUS® (ocrelizumab), a prescription medicine used for multiple sclerosis (MS) treatment in adults with relapsing or primary progressive multiple sclerosis. See full safety for more information.
Ocrevusevents.com is ranked number 10M in the world and links to network IP address 34.236.42.229.
Learn about Genentech Access Solutions, a resource that provides helpful access and reimbursement support to assist your patients and practice.
OCREVUS® (ocrelizumab) is an IV infusion treatment option for your patients with relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS). See full safety for more information.
Multiple Sclerosis News Today Home - Multiple Sclerosis News Today.
Fighting MS with Ocrevus (Ocrelizumab).
A resource for Information and Links for Multiple Sclerosis
Welcome To MS-Go - MS-Go Multiple Sclerosis Event Calendar.
Learn about XOLAIR®, a self-administered treatment for allergic asthma, chronic rhinosinusitis with nasal polyps, chronic spontaneous urticaria, and food allergy. See full prescribing, safety, & Boxed Warning info.
Learn about XOLAIR®, a self-administered treatment for allergic asthma, chronic rhinosinusitis with nasal polyps, chronic spontaneous urticaria, and food allergy. See full prescribing, safety, & Boxed Warning info.
Patient Saving Program.
Breakthrough science. One moment, one day, one person at a time.
Learn about Esbriet® (pirfenidone), a medication for the treatment of idiopathic pulmonary fibrosis (IPF), a progressive and irreversible fibrotic interstitial lung disease. See full safety for more information.
Learn about Esbriet® (pirfenidone) as a possible treatment option for IPF, a progressive and irreversible fibrotic interstitial lung disease. See full safety for more information.
Ofev.com is ranked number 10M in the world and links to network IP address 45.60.109.115.
Multiplesclerosis.net is ranked number 792460 in the world and links to network IP address 104.25.132.7.
Providing information you can trust, supporting the MS specialists you need.
Nationalmssociety.org is ranked number 44825 in the world and links to network IP address 52.176.6.37.
Multiple sclerosis news, information, research, and support for everyone affected by MS
Welcome to the Multiple Sclerosis Association of America (MSAA) – a leading resource for the entire MS community, improving lives today through vital services and support.
Bethy Bright and Dark – My MS (Mis)Adventure.
A premier multiple sclerosis resource empowering patients, caregivers and healthcare providers with trusted, evidence-based content.
A day in the life with multiple sclerosis
Wheelchair Kamikaze.
Sign in - Google Accounts.
Learn about the benefits and risks with PLEGRIDY® (peginterferon beta-1a) relapsing multiple sclerosis (MS) treatment. See full Prescribing & Safety Information.
Rebif® (interferon beta-1a) is a treatment for your relapsing multiple sclerosis (RMS) that delivers proven efficacy and a well-established safety profile.
Working together to improve the quality of life for those with Multiple Scherosis and their families.
Aubagio.com is ranked number 1010208 in the world and links to network IP address 205.137.77.87.
Patients and Caregivers Home | Genentech XOLAIR Co-Pay Program.
Learn more about chronic spontaneous urticaria, or CSU, which is the medical term for chronic hives that have no known cause and last for six weeks or longer.
Itchingforanswers.ca is ranked number 10M in the world and links to network IP address 107.154.148.134.
Learn more about NUCALA (mepolizumab), a maintenance treatment for patients with severe eosinophilic asthma. NUCALA is not used for sudden breathing problems.
Breakthrough science. One moment, one day, one person at a time.
Information for HCPs regarding Rituxan® (rituximab), the first FDA-approved induction treatment for patients with GPA & MPA. See full safety and Boxed Warning for more information.
Find information for patients about treatment with ALECENSA® (alectinib). See full safety for more information.
As a pioneer in healthcare, we have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
AbbVie pharmaceuticals combines advanced science with expertise to make strides in drug and treatment discovery, making a remarkable impact on people's lives
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Working together, we can reimagine medicine to improve and extend people’s lives.
Idiopathic Pulmonary Fibrosis educational information and real life topics for patients living with IPF, written by expert pulmonologist Dr. Jeremy Feldman.
Learn about idiopathic pulmonary fibrosis (IPF) and gain access to IPF resources & support–like tips to manage IPF symptoms–for patients and caregivers.
Learn about the key aspects of idiopathic pulmonary fibrosis (IPF) and test your knowledge as you go with our interactive quizzes.
Learn about OFEV® (nintedanib), an option for patients with Idiopathic Pulmonary Fibrosis (IPF), Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD), & Chronic Fibrosing ILDs with a Progressive Phenotype. View full prescribing information, including patient information and important safety information.